Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Immersive Virtual Reality-based Cognitive Remediation in Patients With Mood Disorders or Psychosis Spectrum Disorders: a Randomized, Controlled, Double-blinded Trial

NCT06038955 is registered in ClinicalTrials.gov with Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital as lead sponsor.

NCT NCT06038955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06038955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Immersive Virtual Reality-based Cognitive Remediation in Patients With Mood Disorders or Psychosis Spectrum Disorders: a Randomized, Controlled, Double-blinded Trial
Lead sponsor
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2022
Completion date
December 13, 2024
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, cognitive impairment, depression, psychotic disorders, schizophrenia, schizotypal disorder